Table 1. Donors of islets used in the study.

Donor no.	Donor gender	Donor age (Y)	Donor BMI	Islet purity (%)	Cell viability (%)
1	M	40	29	95	NA
2	F	62	27	95	71
3	F	13	24	88	65
4	F	66	24	82	58
5	F	58	27	99	70
6	F	54	29	83	73
7	M	46	24	74	70
8	F	45	26	90	66
9	M	41	22	70	NA
10	F	32	27	80	78
11	F	44	22	85	52
12	F	63	23	70	76
13	M	34	28	85	81
14	F	46	33	80	68
15	M	59	25	85	43
16	M	52	21	80	50
17	M	29	26	70	NA
18	M	34	28	90	71
19	F	44	35	95	76
20	M	48	18	90	77
21	M	49	31	90	65
22	M	45	27	85	74
23	F	20	25	85	43
24	F	51	21	85	65
25	F	41	36	90	65
26	F	47	21	90	NA
27	M	31	29	85	59
28	F	60	35	80	75
29	F	32	29	80	44
30	F	44	33	90	79
31	F	48	37	90	58
32	F	51	29	88	40
33	M	62	28	80	73
34	F	49	37	94	63
35	F	47	30	90	57
36	F	61	31	90	70
37	F	45	34	80	76
38	F	29	21	90	80
39	F	48	33	90	67
40	M	48	31	80	79
41	M	15	23	90	67
42	F	47	33	70	NA
43	F	27	23	70	NA
44	M	21	34	85	71
45	M	44	25	99	80
46	M	27	19	85	57
47	M	39	27	98	66
48	M	42	35	92	82
49	M	38	30	85	71
50	M	29	30	95	88
51	M	42	33	93	82
52	F	49	27	90	63
53	M	54	33	85	NA
54	M	62	19	92	69
55	M	50	28	85	70
56	M	47	33	90	70
57	F	48	22	95	78
Mean±SD		44±12	28±5	86±7	68±8